Educating Parents About Meningococcal Disease
Pfizer has partnered with The Kimberly Coffey Foundation on a National Meningococcal Disease Awareness Survey to better understand parents’ knowledge of meningococcal disease and available vaccines.
One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options
Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.
One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options
Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.
How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile
When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.
How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile
When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.
Behind the Science: A New Path to Tackling Metastatic Breast Cancer
In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.
Behind the Science: A New Path to Tackling Metastatic Breast Cancer
In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.
Hiding in Plain Sight: The Racial Toll of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.
Hiding in Plain Sight: The Racial Toll of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.
Behind the Science: Breaking the Cycle of C. difficile
The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing! Clostridioides difficile, also known as C. difficile, is one such bacterium.
Behind the Science: Breaking the Cycle of C. difficile
The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing! Clostridioides difficile, also known as C. difficile, is one such bacterium.
One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options
Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.
One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options
Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.
How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile
When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.
How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile
When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.
Behind the Science: A New Path to Tackling Metastatic Breast Cancer
In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.
Behind the Science: A New Path to Tackling Metastatic Breast Cancer
In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.
Hiding in Plain Sight: The Racial Toll of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.
Hiding in Plain Sight: The Racial Toll of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States. New research indicates that people of color are more likely to develop more severe Lyme disease.
Behind the Science: Breaking the Cycle of C. difficile
The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing! Clostridioides difficile, also known as C. difficile, is one such bacterium.
Behind the Science: Breaking the Cycle of C. difficile
The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing! Clostridioides difficile, also known as C. difficile, is one such bacterium.